BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1701 related articles for article (PubMed ID: 30104265)

  • 1. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 2. Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease.
    Jhun BW; Yang B; Moon SM; Lee H; Park HY; Jeon K; Kwon OJ; Ahn J; Moon IJ; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.
    Kwon YS; Koh WJ
    J Korean Med Sci; 2016 May; 31(5):649-59. PubMed ID: 27134484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of species change of Nontuberculous Mycobacteria during or after treatment.
    Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ
    BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.
    Park J; Cho J; Lee CH; Han SK; Yim JJ
    Clin Infect Dis; 2017 Feb; 64(3):301-308. PubMed ID: 28011609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing Epidemiology of Nontuberculous Mycobacterial Lung Diseases in a Tertiary Referral Hospital in Korea between 2001 and 2015.
    Ko RE; Moon SM; Ahn S; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Koh WJ
    J Korean Med Sci; 2018 Feb; 33(8):e65. PubMed ID: 29441757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and treatment outcomes of pleural effusions in patients with nontuberculous mycobacterial disease.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Dec; 133():36-41. PubMed ID: 29173447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.
    Morimoto K; Hasegawa N; Izumi K; Namkoong H; Uchimura K; Yoshiyama T; Hoshino Y; Kurashima A; Sokunaga J; Shibuya S; Shimojima M; Ato M; Mitarai S
    Ann Am Thorac Soc; 2017 Jan; 14(1):49-56. PubMed ID: 27788025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
    Moon SM; Jhun BW; Baek SY; Kim S; Jeon K; Ko RE; Shin SH; Lee H; Kwon OJ; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Koh WJ
    Respir Med; 2019 May; 151():1-7. PubMed ID: 31047103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Treatment Outcomes of Pulmonary Diseases Caused by Coinfections With Multiple Nontuberculous Mycobacterial Species.
    Kim S; Woo A; Yong SH; Leem AY; Lee SH; Lee SH; Kim SY; Chung K; Kim EY; Jung JY; Kang YA; Park MS; Kim YS; Park Y
    J Korean Med Sci; 2024 May; 39(20):e167. PubMed ID: 38804011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
    Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ
    Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
    Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
    Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
    Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of time for diagnosis of nontuberculous mycobacterial lung disease and its associated factors in a tuberculosis-designated hospital in Shanghai].
    Zheng XB; He YF; Wang L; Sun Q; Shen XN; Wu XC; Yang JH; Yao L; Cui HY; Xu B; Yu FY; Sha W
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):380-387. PubMed ID: 36990702
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinico-microbiological analysis of 121 patients with pulmonary Mycobacteroides abscessus complex disease in Japan - An NTM-JRC study with RIT.
    Morimoto K; Nakagawa T; Asami T; Morino E; Fujiwara H; Hase I; Tsujimoto Y; Izumi K; Hayashi Y; Matsuda S; Murase Y; Yano R; Takasaki J; Betsuyaku T; Aono A; Goto H; Nishimura T; Sasaki Y; Hoshino Y; Kurashima A; Ato M; Ogawa K; Hasegawa N; Mitarai S
    Respir Med; 2018 Dec; 145():14-20. PubMed ID: 30509703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18 Cases of pulmonary Mycobacterium abscessus: Clinical difference depending on the presence or absence of Mycobacterium avium complex.
    Furuta K; Ito A; Ishida T; Ito Y; Sone N; Takaiwa T; Yokoyama T; Tachibana H; Arita M; Hashimoto T
    J Infect Chemother; 2016 Sep; 22(9):622-8. PubMed ID: 27430867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
    Koh WJ; Jeong BH; Kim SY; Jeon K; Park KU; Jhun BW; Lee H; Park HY; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Kim H; Kwon OJ
    Clin Infect Dis; 2017 Feb; 64(3):309-316. PubMed ID: 28011608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.